(R)-(+)-6-Hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid
CAS: 53101-49-8
Ref. 3D-DCA10149
| 1g | Descatalogado | ||
| 50mg | Descatalogado | ||
| 100mg | Descatalogado | ||
| 250mg | Descatalogado | ||
| 500mg | Descatalogado |
Información del producto
Nombre:
(R)-(+)-6-Hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid
Sinónimos:
- (2R)-6-hydroxy-2,5,7,8-tetramethyl-3,4-dihydro-2H-chromene-2-carboxylic acid
Descripción:
(R)-(+)-6-Hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid (HMCA) is a supplement that is used to treat cancer. HMCA is an acetyl donor and can be used as a substitute for erythromycin. HMCA was shown to inhibit the growth of human breast cancer cells in culture by reacting with lorazepam and lipase to form a reactive intermediate. This compound has been immobilized on ion-exchange resin for use in biodegradable materials and can be used for the treatment of chronic obstructive pulmonary disease (COPD).
Aviso:
Nuestros productos están destinados únicamente para uso en laboratorio. Para cualquier otro uso, por favor contáctenos.
Marca:
Biosynth
Almacenamiento de larga duración:
Notas:
Propiedades químicas
Peso molecular:
250.29 g/mol
Fórmula:
C14H18O4
Pureza:
Min. 95%
MDL:
Punto de fusión:
Punto de ebullición:
Punto de inflamabilidad:
Densidad:
Concentración:
EINECS:
Merck:
Código HS:
